Awards Nomination 20+ Million Readerbase
Indexed In
  • Academic Journals Database
  • Open J Gate
  • Genamics JournalSeek
  • JournalTOCs
  • China National Knowledge Infrastructure (CNKI)
  • Scimago
  • Ulrich's Periodicals Directory
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • Publons
  • MIAR
  • University Grants Commission
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • Google Scholar
Share This Page

Prasanta Kumar Ghosh

Department of Biotechnology, Ministry of Science and Technology, Government of India, New Delhi-110058, India

Biography

Prasanta Kumar Ghosh received his Ph.D. in Electrical Engineering from University of Southern California (USC), Los Angeles, USA in 2011. Prior to that he obtained his M.Sc.(Engineering) in Electrical Communication Engineering from Indian Institute of Science (IISc), Bangalore and B.E.(ETCE) in Electronics from Jadavpur University, Kolkata in 2006 and 2003 respectively. He has been a Research Intern at Microsoft Research India, Currently, he is an associate professor in the department of Electrical Engineering (EE) 

Publications
  • Review Article   
    Effective SARS-CoV-2 Vaccines on the Horizon
    Author(s): Soma Ghosh and Prasanta Kumar Ghosh*

    Novel coronavirus identified as SARS-CoV-2 has brought unprecedented sufferings to people in almost all countries across the globe during the recent time. Efforts are continued to develop effective vaccines against the disease. Presently, the efforts of six groups namely, University of Oxford, Oxford, UK; Sinovac, China; Moderna Inc., USA; Wuhan Institute, China; Beijing Institute, China; and Bio N Tech, Germany are more significant. Noteworthy progress in the development of vaccines is in sight, and by the mid-2021 new vaccines may start appearing in the market. All these six vaccines are deployed through intramuscular route. There are a few others which are in the developmental stage and are to be delivered through intradermal, intranasal and event through the oral route. Specialized adjuvants have been used to elicit stronger immune response in certain types of.. View more»

    DOI: 10.35248/2157-7560.20.11.428

    Abstract HTML PDF